Amgen has welcomed Health Minister Mark Butler's confirmation that the PBS listing of osteoporosis therapy EVENITY (romosozumab) has been expanded to a first-line setting for people who have had one fracture and are at very high risk of another.
Amgen welcomes expanded listing of biologic osteoporosis therapy
November 21, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Australia leads the way as Moderna and MSD take personalised cancer vaccine into lung cancer
October 24, 2026 - - Latest News -
Arrotex bets on Recce's Phase 3 gel as diabetic foot infections get harder to treat
October 23, 2026 - - Latest News -
The imperative is to negotiate with the fifth year of the agreement in mind
October 23, 2026 - - Latest News -
The private medicines boom has mostly passed vaccines by, for now
October 23, 2026 - - Latest News -
BioNTech opens mRNA plant, putting Melbourne's north on the biotech map
October 22, 2026 - - Latest News -
The industry walked out on Britain, and what it cost to win them back
October 22, 2026 - - Latest News -
An architect of the first industry–Commonwealth medicines pact to lead CSL
October 21, 2026 - - Latest News
